vs
Side-by-side financial comparison of OLB GROUP, INC. (OLB) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.8M, roughly 1.3× OLB GROUP, INC.). OLB GROUP, INC. runs the higher net margin — -83.7% vs -365.3%, a 281.6% gap on every dollar of revenue. On growth, Instil Bio, Inc. posted the faster year-over-year revenue change (-19.2% vs -35.2%).
OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
OLB vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8M | $2.2M |
| Net Profit | $-1.5M | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | -83.7% | -426.3% |
| Net Margin | -83.7% | -365.3% |
| Revenue YoY | -35.2% | -19.2% |
| Net Profit YoY | 67.5% | 31.1% |
| EPS (diluted) | $-0.48 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8M | $2.2M | ||
| Q3 25 | $2.3M | $2.2M | ||
| Q2 25 | $2.3M | $2.2M | ||
| Q1 25 | $2.3M | $2.2M | ||
| Q4 24 | $2.7M | $2.8M | ||
| Q3 24 | $3.1M | $1.5M | ||
| Q2 24 | $3.5M | $0 | ||
| Q1 24 | $3.5M | $0 |
| Q4 25 | $-1.5M | $-8.2M | ||
| Q3 25 | $-1.2M | $-13.6M | ||
| Q2 25 | $-2.1M | $-21.4M | ||
| Q1 25 | $-1.1M | $-28.2M | ||
| Q4 24 | $-4.6M | $-11.9M | ||
| Q3 24 | $-1.6M | $-23.0M | ||
| Q2 24 | $-2.6M | $-14.9M | ||
| Q1 24 | $-2.4M | $-24.3M |
| Q4 25 | -83.7% | -426.3% | ||
| Q3 25 | -49.1% | -670.0% | ||
| Q2 25 | -74.8% | -1045.5% | ||
| Q1 25 | -36.6% | -1363.2% | ||
| Q4 24 | -166.0% | -426.1% | ||
| Q3 24 | -52.9% | -1582.8% | ||
| Q2 24 | -74.3% | — | ||
| Q1 24 | -82.6% | — |
| Q4 25 | -83.7% | -365.3% | ||
| Q3 25 | -50.8% | -606.0% | ||
| Q2 25 | -93.7% | -954.2% | ||
| Q1 25 | -46.9% | -1257.8% | ||
| Q4 24 | -167.1% | -428.8% | ||
| Q3 24 | -52.9% | -1541.9% | ||
| Q2 24 | -75.2% | — | ||
| Q1 24 | -67.8% | — |
| Q4 25 | $-0.48 | $-1.13 | ||
| Q3 25 | $-0.13 | $-2.01 | ||
| Q2 25 | $-0.66 | $-3.24 | ||
| Q1 25 | $-0.47 | $-4.32 | ||
| Q4 24 | $-3.55 | $-1.82 | ||
| Q3 24 | $-0.92 | $-3.54 | ||
| Q2 24 | $-1.49 | $-2.29 | ||
| Q1 24 | $-0.14 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.6M | $113.9M |
| Total Assets | $12.3M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $5.8M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | $29.3K | $15.4M | ||
| Q4 24 | $27.4K | $8.8M | ||
| Q3 24 | $41.3K | $6.7M | ||
| Q2 24 | $53.3K | $6.8M | ||
| Q1 24 | $3.3K | $5.5M |
| Q4 25 | $4.6M | $113.9M | ||
| Q3 25 | $5.3M | $120.4M | ||
| Q2 25 | $6.4M | $131.7M | ||
| Q1 25 | $2.3M | $144.9M | ||
| Q4 24 | $3.2M | $169.4M | ||
| Q3 24 | $6.7M | $176.3M | ||
| Q2 24 | $8.3M | $195.0M | ||
| Q1 24 | $11.0M | $205.8M |
| Q4 25 | $12.3M | $203.5M | ||
| Q3 25 | $12.2M | $211.8M | ||
| Q2 25 | $12.4M | $231.0M | ||
| Q1 25 | $12.5M | $237.4M | ||
| Q4 24 | $12.7M | $263.6M | ||
| Q3 24 | $15.9M | $272.6M | ||
| Q2 24 | $16.6M | $294.3M | ||
| Q1 24 | $18.3M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $-7.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.3M | $-7.1M | ||
| Q3 25 | $-115.5K | $-10.6M | ||
| Q2 25 | $-1.0M | $-14.8M | ||
| Q1 25 | $-155.8K | $-4.2M | ||
| Q4 24 | $-2.6M | $-10.6M | ||
| Q3 24 | $-376.7K | $-20.1M | ||
| Q2 24 | $-785.5K | $-10.6M | ||
| Q1 24 | $-424.7K | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLB
| Transaction And Processing Fees | $1.7M | 94% |
| Other | $99.2K | 6% |
TIL
Segment breakdown not available.
